|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Restricted cash | ||||||||||
| Cash and cash equivalents | ||||||||||
| Accounts receivable and other receivable, net of (credit loss allowance of $1,273,113 and $594,869 at June 30, 2026 and 2025, respectively) | ||||||||||
| Other current assets, net of credit loss allowance of $266,953 and $nil | ||||||||||
| Deferred share issuance costs | ||||||||||
| Prepaid expenses | ||||||||||
| Loan receivables, net of credit loss allowance of $453,449 and $nil | ||||||||||
| Total current assets | ||||||||||
| Non-current assets | ||||||||||
| Restricted cash | ||||||||||
| Long-term loan receivables | ||||||||||
| Property and equipment, net | ||||||||||
| Intangible assets, net | ||||||||||
| Right-of-use assets – operating leases | ||||||||||
| Right-of-use assets – finance leases | ||||||||||
| Other non-current assets | ||||||||||
| Total assets | ||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||
| Liabilities: | ||||||||||
| Current liabilities | ||||||||||
| Due to related parties | ||||||||||
| Accounts payable and accrued liabilities | ||||||||||
| Contract liabilities | ||||||||||
| Accrued payroll liabilities | ||||||||||
| Commitment fee payable | ||||||||||
| Convertible notes | ||||||||||
| Operating lease liabilities – current | ||||||||||
| Finance lease liabilities – current | ||||||||||
| Customer deposits | ||||||||||
| Total current liabilities | ||||||||||
| Non-current liabilities | ||||||||||
| Operating lease liabilities – non-current | ||||||||||
| Finance lease liabilities – non-current | ||||||||||
| Deferred income tax liabilities | ||||||||||
| Total liabilities | ||||||||||
| Stockholders’ equity | ||||||||||
| Common stock, US$0.00001 par value, 100,000,000 shares authorized, 45,443,079 and 42,250,934 issued and outstanding as of June 30, 2026 and June 30, 2025, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| (Accumulated deficits) Retained earnings | ||||||||||
| Total stockholders’ equity | ||||||||||
| Total liabilities and stockholders’ equity |
Loading...